Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Brent Hanks, MD, PhD, and his lab team will trial a drug that targets the NLRP3 pathway, so as to unblock immunotherapy from working in melanoma patients.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
DCI's Melanoma (and advanced skin cancer) Disease Group expands Clinic 5-1 services to include dermatological cancer care for patients who require multidisciplinary care.
A decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with melanoma brain metastasis.
Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
April Salama, MD, director of the Melanoma Disease Group, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate medical director.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
William Blake, 65, worked for the State of West Virginia for about 35 years in the toll division before taking early retirement in 2007 when he got si...
A willingness to try a clinical trial, plus his own brand of humor, are helping Tom Drew beat advanced cancer.It would be hard to find a more affable person.
April Salama, MD, interim director of Duke Cancer Institute’s Melanoma Program, has been named a recipient of one of ten 2017 National Cancer Institut...
During the summer of 2016 Dave and Lisa VanTress retired from their jobs in Syracuse, New York, and headed south to the sunny shores of South Carolina...
A new clinic specializing in onco-nephrology — an emerging medical subspecialty that strives to preserve kidney health in cancer patients — has been e...
April Salama, MD, previously interim director of Duke Cancer Institute’s Melanoma disease group, was recently named director.Since assuming the role a...